Summary & Overview
HCPCS K0730: Controlled Dose Inhalation Drug Delivery System
HCPCS Level II code K0730 denotes a controlled dose inhalation drug delivery system — a device intended to deliver a metered or regulated dose of inhaled medication. This code is nationally relevant for payers and providers managing respiratory conditions that require device-based drug delivery, including COPD, asthma, and other obstructive lung diseases where precise dosing and adherence are important.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines coverage considerations and payer variability, summarizes typical sites of service and clinical contexts for device use, and highlights coding benchmarks and policy updates that affect billing for inhalation delivery systems.
Readers will learn what K0730 represents, where the service is commonly provided, and the clinical scenarios in which a controlled dose inhalation system is used. The report also covers national payer coverage themes, common billing modifiers and administrative considerations, and links to related coding topics. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code K0730 describes a controlled dose inhalation drug delivery system. This code represents the device-based delivery of a medication using a metered or otherwise controlled inhalation mechanism.
-
Service type: Device-based respiratory drug delivery
-
Typical site of service: Ambulatory clinics, outpatient respiratory therapy settings, durable medical equipment suppliers, and other outpatient or clinic-based locations where inhalation devices are provided and used
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with moderate-to-severe obstructive lung disease presents to the pulmonary clinic for initiation of or ongoing management with a controlled dose inhalation drug delivery system (K0730). Typical patients include adults with asthma, chronic obstructive pulmonary disease (COPD), or bronchiolitis who require a metered, regulated inhalation device to deliver nebulized or aerosolized medications (e.g., bronchodilators, corticosteroids, inhaled antibiotics). The clinical workflow begins with a physician or advanced practice provider evaluation documenting diagnosis, indication for a controlled dose inhalation system, and prescription of the specific drug formulation. Respiratory therapy or trained clinic staff demonstrate device use, assess inhalation technique, and provide education on dosing frequency, cleaning, and storage. The device may be supplied in the clinic or dispensed via a durable medical equipment supplier; documentation must include device description, quantity supplied, and supporting clinical rationale. Follow-up visits assess symptom control, adherence, and need for device replacement or additional training.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Default, no modifier applicable |